Biocon Limited
BIOCON
Kedudukan dalam Saham
#3440
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
Harga Saham
$3.68
Modal Pasaran
$5.03B
Perubahan (1 hari)
-1.91%
Perubahan (1 tahun)
-11.51%
Negara
IN
Perdagangan Biocon Limited (BIOCON)
Kategori
Healthcare
Sejarah harga saham bagi Biocon Limited (BIOCON)
Harga penutupan tertinggi: $3.90 pada 2026-10-01
Harga penutupan terendah: $1.16 pada 2004-04-01
Harga penutupan terendah: $1.16 pada 2004-04-01
Sejarah harga saham Biocon Limited dari 2004 hingga 2026
Prestasi harga saham tahunan
| Tahun | Prestasi |
|---|---|
| 2026 (TTM) | -0.41% |
| 2025 | 3.10% |
| 2024 | 43.03% |
| 2023 | -9.84% |
| 2022 | -32.34% |
| 2021 | -21.74% |
| 2020 | 51.69% |
| 2019 | -7.50% |
| 2018 | 8.33% |
| 2017 | 76.96% |
| 2016 | 90.65% |
| 2015 | 2.58% |
| 2014 | 4.05% |
| 2013 | 29.61% |
| 2012 | -4.48% |
| 2011 | -38.93% |
| 2010 | 49.26% |
| 2009 | 165.57% |
| 2008 | -69.07% |
| 2007 | 80.35% |
| 2006 | -25.48% |
| 2005 | -5.27% |
| 2004 | 0.00% |
Harga saham bagi syarikat atau pesaing serupa
| Syarikat | Harga saham | Perubahan 1thn% | Negara |
|---|---|---|---|
| $527.18 | 23.67% |
US
|
|
| $251.29 | 814.11% |
US
|
|
| $136.62 | -4.51% |
AU
|
|
| $890.85 | 6.72% |
NL
|
|
| $752.87 | 7.40% |
CH
|
